Non-major histocompatibility complex dependent variations in lymphocyte activity between inbred mouse strains susceptible to various autoimmune diseases

Scandinavian Journal of Immunology

Volumn 52, Issue 1, 2000, Pages 21-29

  Johansson, Å C M ^a   Vestberg, M ^a   Holmdahl, R ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL KINETICS; CONGENIC STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; INBRED STRAIN; LYMPH NODE CELL; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CYTOKINES; DISEASE SUSCEPTIBILITY; LYMPH NODES; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 0033920058     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00738.x     Document Type: Article

References (31)

1. 1 Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154: 688-700.
2. 2 Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980;29:1-13.
3. 3 Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2-T lymphocytes. J Immunol 1981;127:1420-3.
4. 4 Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T-lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 1981;11:195-9.
5. 5 Rodriguez M, Patick AK, Pease LR, David CS. Role of T-cell receptor V beta genes in Theiler's virus-induced demyelination of mice. J Immunol 1992;148:921-7.
6. 6 Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13:179-200.
7. 7 Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol 1998;10:710-17.
8. 8 Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
9. 9 Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-51.
10. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42.
11. + T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-9.
12. 12 Frei K, Eugster HP, Bopst M, Constantinescu CS, Lavi E, Fontana A. Tumour necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997;185:2177-82.
13. 13 Liu J, Marino MW, Wong G, et al. TNF is a potent antiinflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998;4:78-83.
14. 14 Korner H, Riminton DS, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Critical points of tumour necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 1997;186:1585-90.
15. 15 Kageyama Y, Koide Y, Yoshida A, et al. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 1998;161:1542-8.
16. 16 Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 1993;75:263-74.
17. 17 Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 1993;75:274-82.
18. 18 Serreze DV, Chapman HD, Varnum DS, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new 'speed congenic' stock of NOD.Ig mu null mice. J Exp Med 1996;184:2049-53.
19. 19 Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999;11:131-9.
20. 20 Dong P, Hood L, McIndoe RA. Detection of a large RIII-derived chromosomal segment on chromosome 10 in the H-2 congenic strain B10.RIII(71NS)/Sn. Genomics 1996;31:266-9.
21. 21 Lund T, O'Reilly L, Hutchings P, et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain [see comments]. Nature 1990;345:727-9.
22. 22 Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-18.
23. 23 Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997;107:507-12.
24. 24 Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992;149: 2496-505.
25. 25 Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996;44:607-14.
26. 26 Shimada A, Charlton B, Rohane P, Taylor-Edwards C, Fathman CG. Immune regulation in type 1 diabetes. J Autoimmun 1996;9: 263-9.
27. 27 Joosten LA, Lubberts E, Durez P, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
28. 28 Gieni RS, Fang Y, Trinchieri G, Umetsu DT, DeKruyff RH. Differential production of IL-12 in BALB/C and DBA/2 mice controls IL-4 versus IFN-gamma synthesis in primed CD4 lymphocytes. Int Immunol 1996;8:1511-20.
29. 29 Cannella B, Gao YL, Brosnan C, Raine CS. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 1996; 45:735-46.
30. 30 Nagelkerken L, Blauw B, Tielemans M. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice [published erratum appears in Int Immunol 1997;9:1773]. Int Immunol 1997;9:1243-51.
31. 31 Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997;186:299-306.